Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04755595 · ClinicalTrials.gov registry record · Phase 2
Combination Facial Aesthetic Treatment in Millennials
A Phase 2 study, sponsored by State University of New York - Downstate Medical Center.
- Completed
- Registry status
- Phase 2
- Development phase
- 20
- Enrollment target
NCT04755595 is a Phase 2 study that has completed, run by State University of New York - Downstate Medical Center. The registered enrollment target is 20 participants.
The verdict
NCT04755595, a Phase 2 study, has completed, sponsored by State University of New York - Downstate Medical Center.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 20 participants
- Enrollment target
Study Summary
With 63% of consumers willing to consider investing in facial aesthetics and 73% of consumers worldwide expecting to invest in aesthetic treatments in the upcoming year, it is imperative to explore patient satisfaction and psychosocial impact of a multimodal aesthetic treatment in a millennial cohort. The investigators hypothesize that a combination approach to facial aesthetic treatment in a millennial cohort will result in increased patient-reported satisfaction in multiple areas, including perception of aging concerns and quality of life.
Interventions
- DRUG Botox Cosmetic Injectable Product
- DEVICE Juvéderm Voluma XC
- DEVICE Juvéderm Volbella XC
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2021-03-09 |
| Est. Completion | 2021-05-19 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04755595
The ClinicalTrials.gov registry entry for NCT04755595 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is State University of New York - Downstate Medical Center, which has 18 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Botox Cosmetic Injectable Product is the first listed.
NCT04755595 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04755595 about?
NCT04755595 is a clinical study titled "Combination Facial Aesthetic Treatment in Millennials". With 63% of consumers willing to consider investing in facial aesthetics and 73% of consumers worldwide expecting to invest in aesthetic treatments in the upcoming year, it is imperative to explore patient satisfaction and psychosocial impact of a multimodal aesthetic treatment in a millennial cohor...
What is the current status of trial NCT04755595?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 20 participants. The study started on 2021-03-09. Estimated completion is 2021-05-19.
What interventions are being tested in trial NCT04755595?
The interventions under investigation include: Botox Cosmetic Injectable Product (DRUG), Juvéderm Voluma XC (DEVICE), Juvéderm Volbella XC (DEVICE).
Who is sponsoring clinical trial NCT04755595?
This trial is sponsored by State University of New York - Downstate Medical Center, which has 18 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.